NYSE:DLB - Dolby Laboratories Stock Price, Price Target & More

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories declared a quarterly dividend on Tuesday, April 24th. Shareholders of record on Monday, May 7th will be given a dividend of $0.16 per share on Wednesday, May 16th. This represents a $0.64 dividend on an annualized basis and a yield of 1.02%. The ex-dividend date is Friday, May 4th. View Dolby Laboratories' Dividend History.

Dolby Laboratories declared that its Board of Directors has authorized a share repurchase program on Sunday, April 9th 2017, which permits the company to buyback $200,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase up to 3.9% of its shares through open market purchases. Shares buyback programs are often an indication that the company's board believes its shares are undervalued.

Dolby Laboratories, Inc. (NYSE:DLB) released its quarterly earnings data on Tuesday, April, 24th. The electronics maker reported $0.78 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.64 by $0.14. The electronics maker earned $301.36 million during the quarter, compared to analysts' expectations of $300.37 million. Dolby Laboratories had a net margin of 7.64% and a return on equity of 12.73%. The business's revenue was up 12.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.63 EPS. View Dolby Laboratories' Earnings History.

Dolby Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Dolby Laboratories.

Dolby Laboratories issued an update on its third quarter earnings guidance on Tuesday, April, 24th. The company provided EPS guidance of $0.78-0.84 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.97. The company issued revenue guidance of $310-320 million, compared to the consensus revenue estimate of $330.43 million.

5 brokerages have issued twelve-month price objectives for Dolby Laboratories' shares. Their forecasts range from $52.00 to $78.00. On average, they anticipate Dolby Laboratories' stock price to reach $65.20 in the next twelve months. This suggests a possible upside of 3.9% from the stock's current price. View Analyst Ratings for Dolby Laboratories.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Dolby Laboratories include InterDigital (IDCC), TiVo (TIVO), RPX (RPXC), Acacia Research (ACTG), Quarterhill (QTRH), Finjan (FNJN), Joint (JYNT), Digital Turbine (APPS), Liberty Tax (TAX), ITUS (ITUS), XCel Brands (XELB), MGT Capital Investments (MGTI), Research Frontiers (REFR), Marathon Patent Group (MARA) and ARC Group (ARCK).

Media stories about DLB stock have trended somewhat positive this week, Accern reports. The research group identifies negative and positive news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Dolby Laboratories earned a media sentiment score of 0.19 on Accern's scale. They also assigned news coverage about the electronics maker an impact score of 47.25 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Dolby Laboratories' stock is owned by a number of of retail and institutional investors. Top institutional investors include DOLBY DAGMAR (41.00%), DOLBY DAGMAR (40.60%), Bank of Montreal Can (0.27%), Baillie Gifford & Co. (0.21%), American Capital Management Inc. (0.11%) and Denali Advisors LLC (0.04%). Company insiders that own Dolby Laboratories stock include Bob Borchers, Dagmar Dolby, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Michael Bergeron, N William Jasper, Jr, Nicholas Donatiello Jr, Nicholas Donatiello, Jr, Peter C Gotcher and Steven E Forshay. View Institutional Ownership Trends for Dolby Laboratories.

DLB stock was sold by a variety of institutional investors in the last quarter, including Baillie Gifford & Co. and Radnor Capital Management LLC. Company insiders that have sold Dolby Laboratories company stock in the last year include Bob Borchers, Dagmar Dolby, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, N William Jasper, Jr, Nicholas Donatiello Jr, Peter C Gotcher and Steven E Forshay. View Insider Buying and Selling for Dolby Laboratories.

DLB stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, American Capital Management Inc., Contravisory Investment Management Inc., State of Alaska Department of Revenue and Denali Advisors LLC. View Insider Buying and Selling for Dolby Laboratories.

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of DLB stock can currently be purchased for approximately $62.73.

Dolby Laboratories has a market capitalization of $6.65 billion and generates $1.08 billion in revenue each year. The electronics maker earns $201.80 million in net income (profit) each year or $2.20 on an earnings per share basis. Dolby Laboratories employs 2,122 workers across the globe.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]